2nd Quarter - Report

ILLUMINA, INC. for ILLUMINA, INC.

Period 2nd Quarter 2026 Filed Jul 20, 2026 Signed by Jason D. Kaune, Attorney & Agent for Filer

Official filing
Firm
ILLUMINA, INC.
Client
ILLUMINA, INC.
Income
—
Expenses
$300,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions related to National Institutes of Health (NIH) funding

LobbyistCovered position, as disclosed
JENIFER HEALY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Homeland Security HOM

Discussions related to U.S. government disease surveillance programs

LobbyistCovered position, as disclosed
JENIFER HEALY —

Contacted: Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Medicare/Medicaid MMM

H.R. 7118: Genomic Answers for Childrens Health Act of 2026; all provisions

LobbyistCovered position, as disclosed
JENIFER HEALY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7118 (119th)

Trade (domestic/foreign) TRD

General issues related to trade

LobbyistCovered position, as disclosed
JENIFER HEALY —

Contacted: Treasury, Dept of; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.